comparemela.com

Latest Breaking News On - Year report - Page 5 : comparemela.com

Adhoc: EPIC Suisse AG: EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations

EPIC Suisse AG / Key word(s): Quarter Results EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations 28-May-2024 / 06:45 CET/CEST Release

Zurich
Züsz
Switzerland
Lake-geneva
Switzerland-general
Swiss
Swiss-exchange
Alrov-properties-lodgings-ltd-the-group
News-service
Aviv-stock-exchange
Alrov-group

EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations

EPIC Suisse AG / Key word: Quarter Results EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder s reporting obligations 28-May-2024 / 06:45 CET/CEST Release.

Lake-geneva
Switzerland-general
Switzerland
Zurich
Züsz
Swiss
Swiss-exchange
Aviv-stock-exchange
Alrov-group
Alrov-properties-lodgings-ltd-the-group
Alrov-properties

EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations - adhoc - Börsennachrichten

EPIC Suisse AG Key word Quarter Results EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholders reporting obligations 28May2024 0645 CETCEST Release of an ad hoc announceme

Zurich
Züsz
Switzerland
Lake-geneva
Switzerland-general
Swiss
Alrov-group
Swiss-exchange
Alrov-properties-lodgings-ltd-the-group
Aviv-stock-exchange
Alrov-properties

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Melbourne
Victoria
Australia
Frederic-guerard
Arshadm-khanani
Silvana-guerci-lena
Opthea-limited
Vegfd-research
Linkedin
Exchange-commission
Opthea-clinical-development-program
Lifesci-advisors

vimarsana © 2020. All Rights Reserved.